Phlebofe Tablets 600 mg, # 30
Category
Diseases of the veins
Scope of the drug
Heart, vessels, blood
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
thirty
Phlebof tab.
600mg No. 30
Name ENG
PHLEBOPHA
Clinical and pharmacological group
Venotonic drug
ATX code
Diosmin
Dosage
600mg
Structure
1 tablet contains: Active ingredient: diosmin 600 mg
Excipients: gelatin 50 mg, sodium carboxymethyl starch 40 mg, magnesium stearate 10 mg, microcrystalline cellulose up to 1000 mg.
Indications
varicose veins of the lower extremities (elimination of symptoms)
chronic lymphovenous insufficiency of the lower extremities (elimination of symptoms)
acute hemorrhoids (in combination therapy to relieve symptoms)
microcirculation disorders (for example, with idiopathic edema).
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
INN / Active ingredient
Diosmin
Contraindications
hypersensitivity to drug components
children under 18 years of age (experience of use is limited)
I trimester of pregnancy
period of breastfeeding (experience of use is limited).
Specifications
Category
Diseases of the veins
Scope of the drug
Heart, vessels, blood
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
thirty
Scope of application
Phlebology
Minimum age from
18 years
Vacation conditions
Without recipe
Brand name
Ozone OOO
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Angioprotective agent
Anatomical and therapeutic characteristics
C05CA03 Diosmin
Dosage form
Pills
Packaging
Box
Dosage (volume) of the substance in the preparation
1 tablet: diosmin 600 mg
The target audience
Adult
Expiration date in days
1095
Package weight, g
120
Mode of application
:
The drug is intended for oral administration. < br> With varicose veins of the lower extremities and chronic lymphovenous insufficiency. The drug is prescribed 1 tablet per day in the morning on an empty stomach. The duration of therapy is usually 2 months. < br> In severe forms of chronic lymphovenous insufficiency (edema, pain, convulsions, etc.), treatment may be longer (the total duration of continuous therapy should not exceed three to four months). The course of treatment with the drug is repeated after 2-3 months. < br> For the treatment of chronic lymphovenous insufficiency during the II and III trimester of pregnancy, the drug is prescribed 1 tablet once a day. It is necessary to stop taking the drug 2-3 weeks before delivery. < br> In case of exacerbation of hemorrhoids. The drug is prescribed for 2-3 tablets per day with meals for 7 days.Then, if necessary, you can continue taking the drug 1 tablet once a day for 1-2 months. < br> In case of microcirculation disorders. The drug is prescribed 1 tablet per day in the morning on an empty stomach. The duration of therapy is usually 1-2 months. If one or more doses of the drug are missed, you must continue using the drug as usual and at the usual dose. < br> < br>